Home Mainline IPOs Hamps Bio IPO
Orion Industries logo

Hamps Bio IPO

Open Sme
BSE 13 December - 17 December 2024
Hamps Bio Limited IPO is a fixed price issue of 6.22 Cr. The issue is entirely a fresh issue of 1220000 shares aggregating to 6.22 Cr. Hamps Bio Limited IPO opened for subscription on Dec 13, 2024 and closed on Dec 17, 2024. The allotment for the this IPO was finalized on Dec 18, 2024. IPO was listed on NSE and BSE on Dec 20, 2024. Hamps Bio Limited IPO has set the issue price at ₹51 per share.

Current GMP

₹60 (+117.65%)

Price Band

₹ 51 – 51

Lot Size

2000

Issue Size

₹6.22 Cr

Minimum Investment

₹204000 (4000 Shares)

Listing Date

20 December 2024

Subscription

1057.06x

About the Company

Hamps Bio Limited is a company engaged in the ethical marketing and distribution of pharmaceutical products and the manufacturing of freeze-dried and frozen food products. The company operates under two main divisions: the Pharmaceutical Products Division (Pharma) and the Freeze Dried and Frozen Products (FDFP or FMCG) Division.

Pharmaceutical Products Division

Founded in 2007, Hamps Bio started as an ethical pharmaceutical marketing firm in Gujarat, distributing a variety of pharmaceutical products. These products, such as tablets, syrups, capsules, injectables, and powders, cover a range of therapeutic areas including pediatric care, painkillers, antibiotics, and nutrition supplements. The products are marketed under the brand name “Hamps” and sourced from 16 WHO GMP certified contract manufacturers. The company operates a systematic distribution model, utilizing a network of over 50 distributors and a marketing team that serves approximately 8,000 doctors and medical stores each month, facilitating the sale of 60,000 units. Its main focus is on the domestic market in India, particularly targeting doctors in specialties such as orthopedics, gynecology, dermatology, and surgery.

Freeze Dried and Frozen Products Division (FDFP)

Launched in 2017, this division focuses on the manufacturing of freeze-dried and frozen products, including fruits, vegetables, herbs, and flowers. These products are processed using lyophilization (freeze-drying) technology and are sold both under the brand “FzyEzy” and through contract manufacturing. Hamps Bio’s FDFP products cater to both B2B and B2C business models, supplying industries such as flavor tea, soups, nutrition bars, chocolates, and ice cream, as well as being sold directly to consumers via e-commerce platforms like Amazon and Flipkart. The manufacturing facility in Gujarat is equipped with modern technology and certified with ISO 9001:2015, ISO 22000:2018, FSSAI, and U.S. FDA accreditations.

Hamps Bio has an extensive distribution network, selling its products across 8 Indian states for pharmaceuticals and in 6 countries and 22 states for its freeze-dried food products. The company’s focus on quality control and innovation has allowed it to expand both domestically and internationally.

Promoters

  1. Herrik Shah
  2. Shrenik Shah
  3. Pallavi Shah
  4. Mitali Shah
  5. Herrik Shah HUF
  6. Shrenik Shah HUF
Promoters Holding

Holding Pre Issue

100.00%

Holding Post Issue

71.99%

Objects of the Issue

The Company intends to use its proceeds as follows:

  1. Purchase of plant & machinery for FMCG division
  2. Enhancing the visibility and awareness of the brand
  3. General corporate purposes

Address / Contact Info

Hamps Bio Limited
2900/112, GIDC, Near
Atul Limited, Ankelshwar
Bharuch – 393 002
Gujarat

 Phone: +91 8000006663
Email: info@hampsbio.com
Website: http://www.hampsbio.com

IPO Snapshot

Face Value₹10 per share
Price Band₹ 51 – 51
Lot Size2000
Issue TypeFixed price IPO
Sale Type
Fresh Issue₹ 6.22 Cr
Offer for Sale₹ 0.00 Cr
Total Issue Size₹ 6.22 Cr
Listing AtBSE
Industry
Sector
Retail Quota47.46%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Hamps Bio IPO is a Fixed price IPO worth ₹6.22 crores. The price band is ₹51 to 51 per share. The IPO opens on Fri, Dec 13, 2024 and closes on Tue, Dec 17, 2024. It will be listed on BSE and NSE. Bigshare Services Pvt Ltd is the registrar.

The Hamps Bio IPO opens on Fri, Dec 13, 2024 and closes on Tue, Dec 17, 2024

Hamps Bio IPO Price Band is ₹51 to 51.

Hamps Bio IPO lot size is 2000, and the minimum amount required for application is ₹204000.

The minimum investment for Hamps Bio IPO is approximately ₹204000 based on the upper price band.

To apply for the Hamps Bio IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Tue, Dec 17, 2024. After submission, funds are blocked until the basis of allotment of Hamps Bio IPO is finalised.

Hamps Bio IPO issue size is ₹6.22 crores.

Hamps Bio IPO allotment date is Sat, Jun 27, 2026.

The registrar for Hamps Bio IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website for IPO allotment status, refund processing, and other queries related to Hamps Bio IPO through their official website or helpline.

The Hamps Bio IPO GMP (Grey Market Premium) is ₹60 as of Fri, Dec 20, 2024. Based on the upper price band of ₹51 per share, the estimated Hamps Bio IPO listing price is ₹111, indicating a potential listing gain of approximately 31% over the issue price.